Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Rotavapor® R-210/R-215

Product Image
Product Description

The Rotavapors R-210/215 can be used for all kind of applications in different kind of laboratories. It not only combines maximum safety for the user but also for the product. The complete solution with vacuum controller, vacuum pump and recirculating chiller allows you to evaporate your solvents in the most efficient and gentle way.

The Rotavapor R-210/215 features the following advantages:

•    Maximum safety for the user and the product
•    Complete solution with vacuum controller, vacuum pump and recirculating chiller
•    Long-life seals provide practically maintenance-free operation and increase service life
•    A wide range of glass assemblies covers numerous applications
•    Compact assembly with small footprint
•    Wireless contacts on the heating bath for both power supply and communications
•    Proven BUCHI quality

Product Rotavapor® R-210/R-215
Company BUCHI Labortechnik AG
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BUCHI Labortechnik AG
Meierseggstrasse 40 Postfach CH-9230 Flawil 1 Switzerland

Tel: +41 71 394 63 63
Fax: +41 71 394 64 64
Email: buchi@buchi.com



Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!